C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
出版年份 2023 全文链接
标题
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
作者
关键词
-
出版物
Lancet Diabetes & Endocrinology
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-11-04
DOI
10.1016/s2213-8587(23)00267-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes
- (2023) Gregory P. Forlenza et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type 1 diabetes
- (2023) Teresa Quattrin et al. LANCET
- Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia
- (2021) Rose A. Gubitosi-Klug et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2021) Matthias von Herrath et al. Lancet Diabetes & Endocrinology
- Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2021) Stephen E Gitelman et al. Lancet Diabetes & Endocrinology
- Immunotherapy for type 1 diabetes
- (2021) L A Allen et al. BRITISH MEDICAL BULLETIN
- IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
- (2021) Carla J. Greenbaum et al. JCI Insight
- HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the influence of technology and socio-economic status on HbA1c in the T1D Exchange Clinic Registry Findings.
- (2020) Kellee M. Miller et al. Diabetes Technology & Therapeutics
- Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes
- (2020) Paolo Pozzilli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications
- (2020) Anita Jeyam et al. DIABETES CARE
- Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
- (2020) Teresa Quattrin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human plasma‐derived alpha 1 ‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study
- (2020) William H. Lagarde et al. PEDIATRIC DIABETES
- Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1cin New-Onset Type 1 Diabetes
- (2018) Michael J. Haller et al. DIABETES CARE
- Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
- (2018) Araz Rawshani et al. LANCET
- Validation of the BETA-2 Score: An Improved Tool to Estimate Beta Cell Function After Clinical Islet Transplantation Using a Single Fasting Blood Sample
- (2016) S. Forbes et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
- (2015) Richard A. Insel et al. DIABETES CARE
- Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010
- (2015) Shona J. Livingstone et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
- (2014) Ronnie Aronson et al. DIABETES CARE
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protege Trial
- (2013) W. Hagopian et al. DIABETES
- The Effects of Inpatient Hybrid Closed-Loop Therapy Initiated Within 1 Week of Type 1 Diabetes DiagnosisDiabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups
- (2013) Diabetes Technology & Therapeutics
- The clinical utility of C-peptide measurement in the care of patients with diabetes
- (2013) A. G. Jones et al. DIABETIC MEDICINE
- Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study
- (2013) P. Ambery et al. DIABETIC MEDICINE
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
- (2013) Mark R Rigby et al. Lancet Diabetes & Endocrinology
- Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
- (2013) Stephen E Gitelman et al. Lancet Diabetes & Endocrinology
- SUITO Index for Evaluation of Clinical Islet Transplantation
- (2012) Morihito Takita et al. CELL TRANSPLANTATION
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
- (2011) Diane K Wherrett et al. LANCET
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Failure to Preserve -Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes
- (2010) P. A. Gottlieb et al. DIABETES CARE
- New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes
- (2009) H. B. Mortensen et al. DIABETES CARE
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started